Provided by Tiger Trade Technology Pte. Ltd.

Enhabit, Inc.

11.20
+0.13001.17%
Post-market: 11.200.00000.00%17:06 EST
Volume:1.92M
Turnover:21.30M
Market Cap:566.80M
PE:-46.67
High:11.28
Open:10.98
Low:10.79
Close:11.07
52wk High:11.45
52wk Low:6.47
Shares:50.61M
Float Shares:40.19M
Volume Ratio:1.70
T/O Rate:4.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2400
EPS(LYR):-3.1116
ROE:-1.69%
ROA:3.06%
PB:1.00
PE(LYR):-3.60

Loading ...

Enhabit Inc. schedules fourth quarter and full-year earnings call

Reuters
·
Feb 13

Enhabit and Encompass Health Secure $43.1 Million in Delaware Fiduciary Breach Case

Reuters
·
Feb 12

Enhabit and Encompass Health Collect $43.1 Million From Individual Defendants in Delaware Fiduciary Breach Case

THOMSON REUTERS
·
Feb 12

Enhabit Inc : Oppenheimer Raises to Outperform From Perform

THOMSON REUTERS
·
Jan 22

Analysts’ Top Healthcare Picks: CytomX Therapeutics (CTMX), Enhabit, Inc (EHAB)

TIPRANKS
·
Jan 22

Enhabit Shares up 3% Premarket After TD Cowen Raises to 'Buy'

THOMSON REUTERS
·
Jan 13

Enhabit Inc : TD Cowen Raises to Buy From Hold; Raises Target Price to $12 From $9

THOMSON REUTERS
·
Jan 13

Enhabit Inc : UBS Raises to Buy From Neutral

THOMSON REUTERS
·
Jan 08

UBS Upgrades Enhabit to Buy From Neutral, Adjusts Price Target to $12 From $8.50

MT Newswires Live
·
Jan 08

Enhabit Raised to Buy From Neutral by UBS

Dow Jones
·
Jan 08

Enhabit upgraded to Buy from Neutral at UBS

TIPRANKS
·
Jan 08

Truist Initiates Enhabit at Hold With $10.50 Price Target

MT Newswires Live
·
Jan 07

Enhabit Executives to Join Bank of America Home Care Conference Fireside Chat

Reuters
·
Dec 03, 2025

Analysts Offer Insights on Healthcare Companies: Cencora (COR), Dyne Therapeutics (DYN) and Enhabit, Inc (EHAB)

TIPRANKS
·
Nov 06, 2025

BRIEF-Enhabit Q3 EPS USD 0.22

Reuters
·
Nov 06, 2025

Enhabit Inc expected to post earnings of 12 cents a share - Earnings Preview

Reuters
·
Nov 04, 2025

Enhabit Inc. to Join UBS Global Healthcare Conference

Reuters
·
Oct 29, 2025